A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...

The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

California Democratic Rep. Doris Matsui has advanced to the November ballot after facing a reelection challenge from a ...

The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...

A phase I trial published in Lancet Gastroenterology & Hepatology found that imdusiran, an investigational small interfering ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...